Home : Unsafe Drugs : Bisphosphonates : Newsfeeds

Bisphosphonates - Newsfeeds

Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released its new report, "Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Bone Metastases ...
European Medicines Agency Concludes Class Review Of Bisphosphonates And Atypical Fractures
Vantavo and Zometa ) can be found on the Agency's website. 4. The review of nationally authorised bisphosphonates was conducted in the context of a formal review under Article 31 of Directive 2001/83/EC, as amended.
Researchers discover strategy that promotes new blood vessel formation
Researchers at The University of Western Ontario have discovered a strategy for stimulating the formation of highly functional new blood vessels in tissues that are starved of oxygen. Dr. Geoffrey Pickering and Matthew Frontini at the Schulich School of ...
CytRx Announces the Presentation of Bafetinib Study Results at the American Academy for Cancer Research (AACR) Annual Meeting
As a parallel, the same type of cells were treated with zoledronic acid (Zometa), an inhibitor of osteoclast formation and bone resorption currently used to prevent skeletal complications for patients with multiple myeloma, metastatic bone diseases or osteoporosis.
Amgen's CEO Discusses Q1 2011 Results - Earnings Call Transcript
Looking at patients on XGEVA to date, in oncology clinics, 2/3 of our patients were previously treated with an intravenous bisphosphonate, primarily Zometa, of course, and the remaining 1/3 were new to treatment. All these patients, about half of them were ...
Ahead of the Bell: Amgen rises on Xgeva study data
Jefferies & Co. analyst Eun Yang said the results make Xgeva a stronger competitor to Novartis AG's bone drug Zometa, as Xgeva is more effective than Zometa at treating bone metastases. She said there are no approved drugs for preventing cancer from ...
Warner Chilcott (WCRX) Announces European Ops Restucturing
From the release: "Warner determined to proceed with the restructuring following the completion of a strategic review of its operations in its Western European markets where its product ACTONEL (risedronate sodium) lost exclusivity in late 2010.
Low Glucose Levels May Raise Death Risk Among Older People
Research shows those over 60 do best with intermediate control over blood sugar MONDAY, April 18 (HealthDay News) -- New research finds that older diabetics with better control of their blood sugar face less chance of such diabetes-related complications as ...
Many With Autism Also Have Treatment-Resistant Epilepsy: Study
Autistic children with epilepsy also tended to be more impaired than those without epilepsy. About 54 percent of those with treatment-resistant epilepsy had motor skills delays, compared to 35 percent of those with treatable epilepsy. Also, those with ...
Squeezing Docs, Hiking Insurance, Hooking Patients
It sold risk of diseases like heart events for which you'd take a statin like Lipitor, osteoporosis for which you'd take a bone drug like Boniva and asthma attacks for which you'd use a second asthma drug like Advair. Of course, by the very definition of ...
'Jeopardy' champ Short buzzes in on J&C's questions
They say you have as much time as you want to wager, but in reality most of our wagering was done before the last Boniva commercial was over. They give you a piece of scratch paper and a golf pencil, basically, and you make your wager. Either you know how ...
First New Alzheimer's Guidelines In 27 Years Could Mean Earlier Diagnosis
It is why new imaging agents for PET scans, spinal fluid tests and other so-called biomarkers that predict Alzheimer's are becoming so important to researchers and drug companies. The notion of different stages of the disease marks a stark contrast from ...
How Big Pharma's Deceptive Advertising Helps Addict Patients, Screw Over Doctors and Jack Up Insurance Rates
It sold risk of diseases like heart events for which you'd take a statin like Lipitor, osteoporosis for which you'd take a bone drug like Boniva and asthma attacks for which you'd use a second asthma drug like Advair. Of course, by the very definition of ...
14 Years of Hooking Patients, Hiking Premiums, and Squeezing Docs
It sold risk of diseases like heart events for which you’d take a statin like Lipitor, osteoporosis for which you’d take a bone drug like Boniva and asthma attacks for which you’d use a second asthma drug like Advair. Of course, by the very ...
Aging changes in the female reproductive system
The ovaries become less responsive to stimulation by follicle-stimulating hormone ( FSH ) and luteinizing hormone ( LH ). To try to compensate for the decreased response, the body produces more of these ovary-stimulating hormones for a time. The level of ...
Study casts doubts on if women should take calcium
Whereas a decade ago physicians routinely recommended supplements as a way to prevent osteoporosis, a class of drugs called bisphosphonates (with brand names such as Boniva and Reclast) now can be used to help reverse those effects, said Dr. William Hurd ...
Bone drug Zometa flops in breast cancer study
He presented results at a cancer conference in San Antonio. Bone drugs called bisphosphonates, sold as Fosamax, Boniva and Actonel, have long been sold for treating osteoporosis. Those are daily pills; Zometa, sold as Reclast for osteoporosis, is given as ...
Eulogy: Remembering the 2010-11 Phoenix Coyotes
Ladies and gentlemen, we have gathered here to mourn the Phoenix Coyotes. Normally, we would be mourning only a team from a specific year - but this time, we may actually be mourning the franchise itself.  It wouldn't be the first time that this franchise ...
The government is not a household, and shouldn’t be run like one
It’s increasingly well understood — at least among the tiny slice of Americans who read wonkish economic blogs — that thinking about the government as a very big household that happens to employ an army is a bad thing. When economic times are good ...
Rottenstein Law Group Anticipating Multidistrict Litigation of Federal Fosamax Femur Fracture Lawsuits
(New York, NY, April 18, 2011) The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects caused by the drug Fosamax, is anticipating the consolidation of federal lawsuits against Merck, the manufacturer of ...
Do you need a District of Columbia Bisphosphonates attorney? Contact one of our District of Columbia Bisphosphonates attorneys now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages:   1   2   3   4   5   6   ...   Next

Need A Bisphosphonates Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Do you need a District of Columbia Bisphosphonates attorney? Contact one of our District of Columbia Bisphosphonates attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Bisphosphonates Case - Submit Your Information Below

Do you need legal assistance with your Bisphosphonates case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Bisphosphonates Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.